CoChat

When more is not better: 10 ‘don’ts’ in endometriosis management. An ETIC* position statement

Open access

The DOI matches its Crossref record; 136 of the 155 references it cites were found in a registry or an index; 16 of the 152 sources its claims cite were checked for support.

Abstract

A network of endometriosis experts from 16 Italian academic departments and teaching hospitals distributed all over the country made a critical appraisal of the available evidence and definition of 10 suggestions regarding measures to be de-implemented. Strong suggestions were made only when high-quality evidence was available. The aim was to select 10 low-value medical interventions, characterized by an unfavorable balance between potential benefits, potential harms, and costs, which should be discouraged in women with endometriosis. The following suggestions were agreed by all experts: do not suggest laparoscopy to detect and treat superficial peritoneal endometriosis in infertile women without pelvic pain symptoms; do not recommend controlled ovarian stimulation and IUI in infertile women with endometriosis at any stage; do not remove small ovarian endometriomas (diameter <4 cm) with the sole objective of improving the likelihood of conception in infertile patients scheduled for IVF; do not remove uncomplicated deep endometriotic lesions in asymptomatic women, and also in symptomatic women not seeking conception when medical treatment is effective and well tolerated; do not systematically request second-level diagnostic investigations in women with known or suspected non-subocclusive colorectal endometriosis or with symptoms responding to medical treatment; do not recommend repeated follow-up serum CA-125 (or other currently available biomarkers) measurements in women successfully using medical treatments for uncomplicated endometriosis in the absence of suspicious ovarian cysts; do not leave women undergoing surgery for ovarian endometriomas and not seeking immediate conception without post-operative long-term treatment with estrogen–progestins or progestins; do not perform laparoscopy in adolescent women (<20 years) with moderate–severe dysmenorrhea and clinically suspected early endometriosis without prior attempting to relieve symptoms with estrogen–progestins or progestins; do not prescribe drugs that cannot be used for prolonged periods of time because of safety or cost issues as first-line medical treatment, unless estrogen–progestins or progestins have been proven ineffective, not tolerated, or contraindicated; do not use robotic-assisted laparoscopic surgery for endometriosis outside research settings. Our proposal is to better address medical and surgical approaches to endometriosis de-implementing low-value interventions, with the aim to prevent unnecessary morbidity, limit psychological distress, and reduce the burden of treatment avoiding medical overuse and allowing a more equitable distribution of healthcare resources.

Overview

CoChat Summary

TL;DR

This ETIC position statement identifies 10 low-value diagnostic or therapeutic interventions in endometriosis that should generally be discouraged to reduce unnecessary morbidity, psychological distress, treatment burden, and healthcare costs. The authors used expert consensus and GRADE appraisal, making strong-against suggestions only when high-quality evidence was available.

Key findings

  • The paper lists 10 “don’ts”: avoid laparoscopy for superficial peritoneal endometriosis in infertile women without pelvic pain; avoid controlled ovarian stimulation and IUI in endometriosis-associated infertility at any stage; avoid removing small ovarian endometriomas (<4 cm) solely to improve conception before IVF; avoid removing uncomplicated deep endometriotic lesions in asymptomatic women or when medical treatment is effective and well tolerated; avoid systematic second-level diagnostic investigations for known/suspected non-subocclusive colorectal endometriosis or symptoms responding to medical treatment; avoid repeated serum CA-125 or other biomarker follow-up in women successfully using medical treatment for uncomplicated endometriosis without suspicious ovarian cysts; do not omit post-operative long-term estrogen–progestins or progestins after surgery for ovarian endometriomas in women not seeking immediate conception; avoid laparoscopy in adolescent women (<20 years) with moderate–severe dysmenorrhea and clinically suspected early endometriosis before trying estrogen–progestins or progestins; avoid drugs unsuitable for prolonged use as first-line medical treatment unless estrogen–progestins or progestins are ineffective, not tolerated, or contraindicated; and avoid robotic-assisted laparoscopic surgery for endometriosis outside research settings.
  • Evidence grading: quality was high for four topics, moderate for three, and low for three; suggestions were strong-against for four issues and weak-against for six. Strong suggestions were made only when high-quality evidence against an intervention was available.
  • For laparoscopy in infertile women with superficial peritoneal endometriosis, meta-analytic ORs for ongoing pregnancy or live birth were 1.64 (95% CI 1.05–2.57) and 1.94 (95% CI 1.20–3.16); the number needed to treat was 12 and 8, rising to more than 24 or 16 given ≤50% prevalence of minimal/mild endometriosis among women with unexplained infertility, compared with IVF success ~25% and NNT of four.
  • For post-operative endometrioma recurrence, the pooled OR was 0.12 (95% CI 0.05–0.29) in long-term oral contraceptive users versus never users; CA-125 for recurrence had sensitivity 15% and specificity 100%, versus pain relapse 71% and 80%, and abnormal physical examination 82% and 41%; TVS for rectosigmoid endometriosis had sensitivity 91% and specificity 98%.

Methods

  • ETIC network experts from 16 Italian university departments and teaching hospitals participated; a steering committee circulated emails, and a provisional list was refined at a 2-day meeting in Verona on 28–29 October 2016, with 10 self-selected sub-groups each addressing one topic.
  • Sub-groups performed literature searches and critically appraised evidence, also consulting major society guidelines; GRADE was used to classify quality of evidence as high, moderate, low, or very low, and suggestions as strong or weak, with only “weak-against” and “strong-against” considered.
  • Draft reports were circulated by email and discussed at a second 2-day meeting in Frascati on 31 March–1 April 2017, then revised and approved at a third meeting in Catanzaro on 24–25 November 2017; the consensus process was financially supported by IBSA Institut Biochimique SA.

Limitations

  • The paper states that a possible limitation is potential influence from Italian local costs and availability of procedures, since all participants were Italian; it also states that selection of the 10 points was based on expert opinion rather than a robust scientific approach, that other excluded points could be similarly or more important, and that the list is not exhaustive.
  • The paper notes that three of the 10 suggestions (the fifth, sixth, and eighth) are based on low-quality evidence, though experts agreed overtesting/overdiagnosis is frequent in those circumstances.
  • Evident from the text: the process was a qualitative consensus exercise rather than a pre-planned, registered quantitative systematic review, and it received financial support from a pharmaceutical company; one participant declared grants from Ferring and Serono.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1093/hropen/hoz009

Cites

136 of 136 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

11 Valid · 2 Not valid · 89 Not checked · 50 Own results and interpretations

69 more claims · 2 with their cited sources checked

Create a free account to see all 152 claims and to verify the 131 references still open.

See all claims — free account
  • It may state two separate claims as one. 50
  • Probably not a substantial claim. 42

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Show all 136 references

Research works printed but not linked: 3

  1. Berlanda, 2016, Endometriosis: treatment of rectovaginal and bowel disease, UpToDate
  2. Lebovic, 2016, Endometriosis: surgical management of pelvic pain, UpToDate
  3. Royal College of Obstetricians and Gynaecologists, 2013, Fertility: Assessment and Treatment for People with Fertility Problems

Cited by

See all 64

Metadata

Authors
Club, E. E. T. I., Alio, L., Angioni, S., Arena, S., Bartiromo, L., Bergamini, V, Berlanda, N., Bonin, C., Busacca, M., Candiani, M., Centini, G., D’Alterio, M. N., Di Cello, A., Exacoustos, C., Fedele, L., Frattaruolo, M. P., Incandela, D., Lazzeri, L., Luisi, S., Maiorana, A., Maneschi, F., Martire, F., Massarotti, C., Mattei, A., Muzii, L., Ottolina, J., Perandini, A., Perelli, F., Pino, I., Porpora, M. G., Raimondo, D., Remorgida, V, Seracchioli, R., Solima, E., Somigliana, E., Sorrenti, G., Venturella, R., Vercellini, P., Viganó, P., Vignali, M., Zullo, F., & Zupi, E.
Venue
Human Reproduction Open
Published
2019
Volume
2019
Issue
3
Pages
hoz009-hoz009
ISSN
2399-3529 (ISSN-L)
OpenAlex
W2951373423
Cited by
64
References
155
Citations by year
2026: 3 · 2025: 6 · 2024: 10 · 2023: 6 · 2022: 14 · 2021: 14 · 2020: 10 · 2019: 1
FWCI
9.33
Type
journal article
Language
en
Open access
Locations
  • Human Reproduction Open (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion, cc-by-nc)
  • CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion, other-oa)
  • Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion)
  • Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion, other-oa)
  • UNICA IRIS Institutional Research Information System (University of Cagliari) (submittedVersion, other-oa)
  • CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion, other-oa)
  • Use Siena air (University of Siena) (submittedVersion, cc-by-nc)
Funders
Institut Biochimique SA, Lugano, Switzerland
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
  • Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
Keywords
endometriosis, endometriosis treatment, infertility, endometrioma, CA125, estrogen-progestin, progestins, laparoscopy, controlled ovarian stimulation, intrauterine insemination, robot-assisted laparoscopic surgery, colorectal endometriosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: When more is not better: 10 ‘don’ts’ in endometriosis management. An ETIC* position statement. https://app.cochat.ai/papers/10.1093/hropen/hoz009
The paper
Club, E. E. T. I., Alio, L., Angioni, S., Arena, S., Bartiromo, L., Bergamini, V, Berlanda, N., Bonin, C., Busacca, M., Candiani, M., Centini, G., D’Alterio, M. N., Di Cello, A., Exacoustos, C., Fedele, L., Frattaruolo, M. P., Incandela, D., Lazzeri, L., Luisi, S., . . . Zupi, E. (2019). When more is not better: 10 ‘don’ts’ in endometriosis management. An ETIC* position statement. Human Reproduction Open. https://doi.org/10.1093/hropen/hoz009

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.